The bone-cartilage unit in osteoarthritis

Nature Reviews Rheumatology

Volumn 7, Issue 1, 2011, Pages 43-49

  Lories, Rik J ^a   Luyten, Frank P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; COLLAGENASE 3; FRIZZLED PROTEIN; GROWTH DIFFERENTIATION FACTOR 5; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEINASE ACTIVATED RECEPTOR 2; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 3; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

BIOMECHANICS; BONE STRESS; CARTILAGE; CARTILAGE DEGENERATION; CARTILAGE INJURY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; IMMUNOPATHOGENESIS; IN VITRO STUDY; JOINT FUNCTION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MUSCULOSKELETAL FUNCTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOLYSIS; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REACTOR CASCADE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT BEARING;

BIOMECHANICS; BONE AND BONES; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; HUMANS; JOINTS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 78650975710     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.197     Document Type: Review

References (59)

1. Hunter, D. J. & Felson, D. T. Osteoarthritis. BMJ 332, 639-642 (2006).
2. Lane, N. E. Clinical practice. Osteoarthritis of the hip. N. Engl. J. Med. 357, 1413-1421 (2007).
3. Felson, D. T. Clinical practice. Osteoarthritis of the knee. N. Engl. J. Med. 354, 841-848 (2006).
4. Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26-35 (2008).
5. Berenbaum, F. New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res. Ther. 10 (Suppl. 2), 1 (2008).
6. Felson, D. T., Anderson, J. J. & Meenan, R. F. The comparative efficacy and toxicity of second?line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum. 33, 1449-1461 (1990).
7. Li, Y., Xu, L. & Olsen, B. R. Lessons from genetic forms of osteoarthritis for the pathogenesis of the disease. Osteoarthritis Cartilage 15, 1101-1105 (2007).
8. Miyamoto, Y. et al. A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet. 39, 529-533 (2007).
9. Valdes, A. M. & Spector, T. D. The contribution of genes to osteoarthritis. Rheum. Dis. Clin. North Am. 34, 581-603 (2008).
10. Valdes, A. M. & Spector, T. D. The clinical relevance of genetic susceptibility to osteoarthritis. Best Pract. Res. Clin. Rheumatol. 24, 3-14 (2010).
11. Southam, L. et al. An SNP in the 5′?UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum. Mol. Genet. 16, 2226-2232 (2007).
12. Evangelou, E. et al. Large?scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum. 60, 1710-1721 (2009).
13. Baker-LePain, J. C. & Lane, N. E. Relationship between joint shape and the development of osteoarthritis. Curr. Opin. Rheumatol. 22, 538-543 (2010).
14. Brandt, K. D., Radin, E. L., Dieppe, P. A. & van de Putte, L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann. Rheum. Dis. 65, 1261-1264 (2006).
15. Sellam, J. & Berenbaum, F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol. 6, 625-635 (2010).
16. Luyten, F. P., Lories, R. J., Verschueren, P., de Vlam, K. & Westhovens, R. Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract. Res. Clin. Rheumatol. 20, 829-848 (2006).
17. Goldring, M. B. & Goldring, S. R. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. NY Acad. Sci. 1192, 230-237 (2010).
18. Thambyah, A. & Broom, N. On new bone formation in the pre-osteoarthritic joint. Osteoarthritis Cartilage 17, 456-463 (2009).
19. Radin, E. L. & Rose, R. M. Role of subchondral bone in the initiation and progression of cartilage damage. Clin. Orthop. Relat. Res. 213, 34-40 (1986).
20. Day, J. S. et al. A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage. J. Orthop. Res. 19, 914-918 (2001).
21. Brown, T. D., Radin, E. L., Martin, R. B. & Burr, D. B. Finite element studies of some juxtarticular stress changes due to localized subchondral stiffening. J. Biomech. 17, 11-24 (1984).
22. Blair-Levy, J. M. et al. A type I collagen defect leads to rapidly progressive osteoarthritis in a mouse model. Arthritis Rheum. 58, 1096-1106 (2008).
23. Muraoka, T., Hagino, H., Okano, T., Enokida, M. & Teshima, R. Role of subchondral bone in osteoarthritis development: a comparative study of two strains of guinea pigs with and without spontaneously occurring osteoarthritis. Arthritis Rheum. 56, 3366-3374 (2007).
24. Daans, M., Luyten, F. P. & Lories, R. J. GDF5 deficiency in mice is associated with instabilitydriven joint damage, gait and subchondral bone changes. Ann. Rheum. Dis. doi:10.1136/ ard.2010.134619
25. Roemer, F. W. et al. Change in MRI?detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann. Rheum. Dis. 68, 1461-1465 (2009).
26. Javaid, M. K. et al. Pre-radiographic MRI findings are associated with onset of knee symptoms: the MOST study. Osteoarthritis Cartilage 18, 323-328 (2010).
27. Raynauld, J. P. et al. Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Ann. Rheum. Dis. 67, 683-688 (2008).
28. Neogi, T. et al. Cartilage loss occurs in the same subregions as subchondral bone attrition: a within-knee subregion-matched approach from the Multicenter Osteoarthritis Study. Arthritis Rheum. 61, 1539-1544 (2009).
29. Roemer, F. W. et al. Subchondral bone marrow lesions are highly associated with, and predict subchondral bone attrition longitudinally: the MOST study. Osteoarthritis Cartilage 18, 47-53 (2010).
30. Neogi, T. et al. Subchondral bone attrition may be a reflection of compartment-specific mechanical load: the MOST Study. Ann. Rheum. Dis. 69, 841-844 (2010).
31. Berry, J. L., Thaeler-Oberdoerster, D. A. & Greenwald, A. S. Subchondral pathways to the superior surface of the human talus. Foot Ankle 7, 2-9 (1986).
32. Imhof, H., Breitenseher, M., Kainberger, F., Rand, T. & Trattnig, S. Importance of subchondral bone to articular cartilage in health and disease. Top. Magn. Reson. Imaging 10, 180-192 (1999).
33. Lyons, T. J., McClure, S. F., Stoddart, R. W. & McClure, J. The normal human chondro?osseous junctional region: evidence for contact of uncalcified cartilage with subchondral bone and marrow spaces. BMC Musculoskelet. Disord. 7, 52 (2006).
34. Walsh, D. A. et al. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 49, 1852-1861 (2010).
35. Madry, H., van Dijk, C. N. & Mueller-Gerbl, M. The basic science of the subchondral bone. Knee Surg. Sports Traumatol. Arthrosc. 18, 419-433 (2010).
36. Bashir, A., Gray, M. L., Boutin, R. D. & Burstein, D. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2) enhanced MR imaging. Radiology 205, 551-558 (1997).
37. Pan, J. et al. In situ measurement of transport between subchondral bone and articular cartilage. J. Orthop. Res. 27, 1347-1352 (2009).
38. Hwang, J. et al. Increased hydraulic conductance of human articular cartilage and subchondral bone plate with progression of osteoarthritis. Arthritis Rheum. 58, 3831-3842 (2008).
39. Luyten, F. P., Tylzanowski, P. & Lories, R. J. Wnt signaling and osteoarthritis. Bone 44, 522-527 (2009).
40. van der Kraan, P. M., Davidson, E. N. & van den Berg, W. B. Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheeps clothing? Osteoarthritis Cartilage 18, 735-741 (2010).
41. Blom, A. B., van Lent, P. L., van der Kraan, P. M. & van den Berg, W. B. To seek shelter from the WNT in osteoarthritis? WNT?signaling as a target for osteoarthritis therapy. Curr. Drug Targets 11, 620-629 (2010).
42. Zhu, M. et al. Activation of catenin signaling in articular chondrocytes leads to osteoarthritislike phenotype in adult catenin conditional activation mice. J. Bone Miner. Res. 24, 12-21 (2009).
43. Zhu, M. et al. Inhibition of catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum. 58, 2053-2064 (2008).
44. Lories, R. J. et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 56, 4095-4103 (2007).
45. Bodine, P. V. et al. The Wnt antagonist secreted frizzled?related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18, 1222-1237 (2004).
46. Weng, L. H., Wang, C. J., Ko, J. Y., Sun, Y. C. & Wang, F. S. Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum. 62, 1393-1402 (2010).
47. Lories, R. J. & Luyten, F. P. Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev. 20, 467-473 (2009).
48. Westacott, C. I., Webb, G. R., Warnock, M. G., Sims, J. V. & Elson, C. J. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum. 40, 1282-1291 (1997).
49. Hilal, G., Martel-Pelletier, J., Pelletier, J. P., Ranger, P. & Lajeunesse, D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum. 41, 891-899 (1998).
50. Massicotte, F. et al. Can altered production of interleukin-1, interleukin-6, transforming growth factor-α and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patientš Osteoarthritis Cartilage 10, 491-500 (2002).
51. Sanchez, C. et al. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum. 58, 442-455 (2008).
52. Mutabaruka, M. S., Aoulad Aissa, M., Delalandre, A., Lavigne, M. & Lajeunesse, D. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res. Ther. 12, R20 (2010).
53. Sanchez, C. et al. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, 1 and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 13, 979-987 (2005).
54. Sanchez, C. et al. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 13, 988-997 (2005).
55. Lin, Y. Y. et al. Applying an excessive mechanical stress alters the effect of subchondral osteoblasts on chondrocytes in a co?culture system. Eur. J. Oral Sci. 118, 151-158 (2010).
56. Prasadam, I. et al. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthritis Rheum. 62, 1349-1360 (2010).
57. Prasadam, I. et al. Osteoarthritic cartilage chondrocytes alter subchondral bone osteoblast differentiation via MAPK signalling pathway involving ERK1/2. Bone 46, 226-235 (2010).
58. Amiable, N. et al. Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts. Bone 44, 1143-1150 (2009).
59. Ferrell, W. R., Kelso, E. B., Lockhart, J. C., Plevin, R. & McInnes, I. B. Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis. Ann. Rheum. Dis. 69, 2051-2054 (2010).